BCM
PTCT icon

Burrage Capital Management’s PTC Therapeutics PTCT Stock Holding History

Burrage Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-160,372
Closed -$7.59M – 27
2021
Q1 		$7.59M Sell
160,372
-711
-0.4% -$42.2K 6.15% 4
2020
Q4 		$9.83M Sell
161,083
-12,462
-7% -$734K 7.49% 2
2020
Q3 		$8.11M Sell
173,545
-5,841
-3% -$288K 6.4% 5
2020
Q2 		$9.1M Sell
179,386
-1,851
-1% -$91K 6.37% 3
2020
Q1 		$8.16M Sell
181,237
-14,488
-7% -$729K 8.03% 2
2019
Q4 		$9.4M Buy
+195,725
New +$8.32M 6.3% 5

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Burrage Capital Management's PTCT Position: Q2 2021 in Review

Burrage Capital Management sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 160,372 shares — an estimated $7.59M sold.

Burrage Capital Management first reported a position in PTCT in Q4 2019 and held it in 6 quarters. The position peaked at $9.83M in Q4 2020. 182 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • Burrage Capital Management reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Burrage Capital Management sold 160,372 PTC Therapeutics shares in Q2 2021, an estimated $7.59M.
  • Burrage Capital Management first reported a position in PTC Therapeutics in Q4 2019 and held it in 6 quarters.
  • Burrage Capital Management's PTC Therapeutics position peaked at $9.83M in Q4 2020.
  • 182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Burrage Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.